Wednesday, July 8, 2026

Drug profile · INN

perflubron

perflubron (IMAGENT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — perflubron
US status
approved
Class
Route
ORAL
Patents
0
Programs
2
Data quality
0.84

Quick answer

perflubron (IMAGENT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN perflubron
Brand IMAGENT
Route ORAL
Formulation LIQUID

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Fludarabine (FLU) Phase 2 · Chinese Academy of · Aplastic Anemia Idiopathic
  2. Rapid test for diagnosis orientation Unknown · Grace Therapeutics · Flu

Frequently asked questions

What is perflubron?

perflubron (IMAGENT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for perflubron?

IMAGENT is a marketed brand name for perflubron. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of perflubron?

perflubron has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.